Spotlight: What’s Being Talked About This Month
The January 2016 PSP shines a "Spotlight" on current beauty trends in the news.
The January 2016 PSP shines a "Spotlight" on current beauty trends in the news.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.